ORIX vs Brown & Brown
Japanese financial group leasing equipment and managing properties vs Financial services company. Which is the better buy for your portfolio in November 2026? Plain-English answer below.
ORIX is a sprawling Japanese conglomerate touching leasing, banking, insurance, real estate, and private equity across Asia, while Brown & Brown is a focused U.S. insurance distribution platform that's compounded earnings for decades through disciplined bolt-on acquisitions. Both are serial acquirers in financial services, but their scope and geographic concentration couldn't be more different. ORIX vs Brown & Brown examines which acquisition-driven growth model allocates capital more efficiently and which valuation better reflects the quality of earnings underneath.
ORIX is a sprawling Japanese conglomerate touching leasing, banking, insurance, real estate, and private equity across Asia, while Brown & Brown is a focused U.S. insurance distribution platform that'...
Why It’s Moving
IX Stock: Leadership Expansion in Capital Formation Signals Strategic Growth Focus
- Lourdes (Fisher) Solis has been appointed as Managing Director, Head of Capital Formation - Americas, based in New York.
- The new role focuses on leading capital formation strategy and deepening strategic relationships with institutional investors.
- This appointment supports ORIX USA's broader objective of facilitating continued growth through strengthened investor relations.
Brown & Brown Boosts Synergy Targets and Deploys AI Platform to Drive Efficiency
- The company increased its 2026 Accession EBITDAC synergy target to $50 million, reflecting improved operational integration outcomes.
- Artificial intelligence software has been deployed to over 6,000 teammates, aiming to enhance productivity and service delivery across the organization.
- A new AI-powered platform called COMPASS was introduced to connect proprietary data with analytics, helping customers optimize their insurance portfolios and better understand risks.
IX Stock: Leadership Expansion in Capital Formation Signals Strategic Growth Focus
- Lourdes (Fisher) Solis has been appointed as Managing Director, Head of Capital Formation - Americas, based in New York.
- The new role focuses on leading capital formation strategy and deepening strategic relationships with institutional investors.
- This appointment supports ORIX USA's broader objective of facilitating continued growth through strengthened investor relations.
Brown & Brown Boosts Synergy Targets and Deploys AI Platform to Drive Efficiency
- The company increased its 2026 Accession EBITDAC synergy target to $50 million, reflecting improved operational integration outcomes.
- Artificial intelligence software has been deployed to over 6,000 teammates, aiming to enhance productivity and service delivery across the organization.
- A new AI-powered platform called COMPASS was introduced to connect proprietary data with analytics, helping customers optimize their insurance portfolios and better understand risks.
Investment Analysis
ORIX
IX
Pros
- ORIX has a diversified financial services portfolio with operations across Japan, the US, Asia, Europe, and Australasia, reducing geographic risk.
- The company reported steady revenue growth in 2024, increasing by 2.15% to approximately 2.87 trillion JPY, accompanied by a 1.58% rise in earnings.
- ORIX maintains a strong asset base in the US through its subsidiaries with $91.3 billion in assets under management and servicing as of mid-2025.
Considerations
- ORIX's future growth prospects are rated relatively low with challenges anticipated in accelerating revenue or earnings expansion beyond recent levels.
- The company's debt-to-equity ratio is high at about 151%, indicating leverage that could impact financial flexibility under adverse conditions.
- Its stock price has shown volatility recently, falling 5.3% from a recent all-time high, signaling potential market uncertainty or valuation risks.
Pros
- Brown & Brown demonstrated strong revenue growth of over 12% and earnings growth exceeding 14% in 2024, reflecting robust operational performance.
- The company has a diversified insurance product portfolio across commercial, public entities and personal lines, spanning multiple countries.
- Analyst sentiment is positive with a majority rating the stock as a 'Buy' and an expected price target implying over 30% upside from current levels.
Considerations
- Brown & Brown's price-to-earnings ratio is relatively elevated at 23.7x, which may imply limited valuation margin compared to peers or historical averages.
- Dividend yield is modest at 0.84%, providing limited income appeal relative to many other financial stocks.
- The stock's 52-week range shows a notable recent decline from its highs near $125 to current levels near $79, indicating market volatility or concerns.
ORIX (IX) Next Earnings Date
The next earnings date for IX has not been confirmed yet. Based on the historical reporting pattern, with the last report released in February 2026, the company is expected to announce its results approximately three months after that period, placing the likely timing around May 2026. This upcoming report will cover the first quarter of fiscal year 2026.
Brown & Brown (BRO) Next Earnings Date
BRO has not yet announced a confirmed date for its next earnings report. Based on the company's historical pattern of reporting approximately three months after the previous quarter, the upcoming release is expected in late January 2027. This report will cover the fourth quarter and full-year results for fiscal 2026.
ORIX (IX) Next Earnings Date
The next earnings date for IX has not been confirmed yet. Based on the historical reporting pattern, with the last report released in February 2026, the company is expected to announce its results approximately three months after that period, placing the likely timing around May 2026. This upcoming report will cover the first quarter of fiscal year 2026.
Brown & Brown (BRO) Next Earnings Date
BRO has not yet announced a confirmed date for its next earnings report. Based on the company's historical pattern of reporting approximately three months after the previous quarter, the upcoming release is expected in late January 2027. This report will cover the fourth quarter and full-year results for fiscal 2026.
Buy IX or BRO in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
